CMND
NASDAQ · Pharmaceuticals
Clearmind Medicine Inc
$0.55
-0.01 (-2.08%)
Open$0.55
Previous Close$0.56
Day High$0.57
Day Low$0.54
52W High$52.40
52W Low—
Volume—
Avg Volume945.6K
Market Cap1.15M
P/E Ratio—
EPS$-53.93
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 523.5K | 483.3K | 576.6K |
| Net Income | 68.9K | 73.1K | 95.7K |
| Profit Margin | 13.2% | 15.1% | 16.6% |
| EBITDA | 118.6K | 102.7K | 135.6K |
| Free Cash Flow | 93.6K | 59.2K | 119.0K |
| Rev Growth | +19.2% | +7.8% | +18.0% |
| Debt/Equity | 0.43 | 0.45 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |